Search filters

List of works by Charles Sawyers

A rectal cancer organoid platform to study individual responses to chemoradiation

scientific article published on 07 October 2019

Author Correction: FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes

scientific article published on 08 September 2020

Challenges in validating candidate therapeutic targets in cancer.

scientific article published on 8 February 2018

Characteristics and Outcome of AKT1 E17K-Mutant Breast Cancer Defined through AACR Project GENIE, a Clinicogenomic Registry

scientific article published on 10 January 2020

Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers

scientific article published in 2021

Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate Cancer

scientific article published on 29 September 2020

GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance

Lineage plasticity in cancer: a shared pathway of therapeutic resistance

scientific article published on 09 March 2020

Modulation of androgen receptor DNA binding activity through direct interaction with the ETS transcription factor ERG

scientific article published on 27 March 2020

Oncogenic ERG Represses PI3K Signaling through Downregulation of IRS2

scientific article published on 03 February 2020

Publisher Correction: Lineage plasticity in cancer: a shared pathway of therapeutic resistance

scientific article published on 17 March 2020

Regenerative potential of prostate luminal cells revealed by single-cell analysis

scientific article published on 01 May 2020

Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer.

scientific article published on 11 September 2017

Somatic tissue engineering in mouse models reveals an actionable role for WNT pathway alterations in prostate cancer metastasis

scientific article published on 06 May 2020

Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death

scientific article published on 04 September 2018

amplifies androgen receptor output in human prostate cancer and contributes to antiandrogen resistance

Paulina is supported by:

About Paulina

Help